LifeVantage Reports Q2 FY26 Revenue of $48.9M, Down 27.8% YoY, and Net Income of $0.02 per Share

LifeVantage reported Q2 FY26 revenue of $48.9 million, down 27.8% YoY, driven by a decline in MindBody GLP-1 System sales. Net income per share was $0.02, compared to $0.19 in Q2 FY25. Adjusted EBITDA was $3.9 million, down from $6.5 million YoY. The company cited challenging competitive dynamics in the weight loss market and plans to stabilize its GLP-1 business and expand into new international markets.